SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-14-002029
Filing Date
2014-05-12
Accepted
2014-05-12 09:20:21
Documents
4
Period of Report
2014-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20140512.htm 8-K 32893
2 EXHIBIT 99.1 rare-ex991_201405126.htm EX-99.1 114842
3 GRAPHIC g2014051000003690418.jpg GRAPHIC 375416
4 GRAPHIC g2014051000003687217.jpg GRAPHIC 7170
  Complete submission text file 0001564590-14-002029.txt   676266
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 14831546
SIC: 2834 Pharmaceutical Preparations